Diagnostics and biomarkers companies develop technologies that detect, monitor and predict disease using biological markers, laboratory testing and analytical platforms. These tools play a critical role in modern healthcare and precision medicine.
This category includes companies working on:
Browse 252 UK diagnostics and biomarkers companies below.
Ultra-sensitive DNA detection platform
InvenireX is developing a nucleic acid detection platform that uses programmable DNA nanostructures captured within microfluidic chips, read by a proprietary AI-powered imaging system. The technology detects genetic markers at concentrations below the threshold of conventional methods such as PCR, with potential to…
Lyophilisation equipment, CDMO services, and freeze-drying expertise
Biopharma Group is a contract development and manufacturing organisation and capital equipment supplier specialising in lyophilisation and liquid formulation technologies. The company serves pharmaceutical, biotechnology, and diagnostics clients across two divisions: an equipment sales and technical service division…
Single-molecule counting point-of-care diagnostics for cardiac and other biomarkers
Psyros Diagnostics develops a point-of-care diagnostic system using single-molecule counting technology to measure biomarkers at extremely low concentrations within around ten minutes, from a single drop of blood. The platform's lead application is a high-sensitivity troponin assay for cardiac diagnosis, with the…
Prospective human biosample collection for translational research
The Sample Network is a clinical research services company arranging human biosample collection for biomarker, diagnostic and therapeutic development. It works with a network of clinical sites to design prospective collection studies tailored to sample type, patient characteristics, processing protocols and associated…
Contract proteomics CRO and inventor of TMT isobaric mass tags
Proteome Sciences is a contract proteomics organisation and reagent manufacturer specialising in mass spectrometry-based protein biomarker discovery, validation, and targeted assay development. Its proprietary workflows serve pharmaceutical and biotechnology clients across drug discovery and clinical research. The…
Non-invasive oral cancer screening using genomics and cell-free DNA
Wisdom Bioscience is a biotechnology company developing a non-invasive oral cancer screening platform that integrates next-generation sequencing and cell-free DNA analysis with saliva-based sample collection. The platform is designed to enable early detection of oral cancer through routine dental appointments,…
AI-powered cancer biomarker profiling from tissue images
Panakeia is an AI diagnostics company developing software that predicts molecular biomarker status directly from standard H&E-stained tissue images. Its CE-marked and UKCA-certified breast cancer product reports ER, PR, and HER2 status in minutes, reducing the need for conventional laboratory testing. The platform…
Reproductive genetic testing and embryo screening for fertility clinics
Igenomix UK is a reproductive genetics laboratory providing diagnostic testing services for fertility clinics and reproductive medicine specialists. Its services include preimplantation genetic testing for chromosomal abnormalities and inherited conditions, alongside carrier screening and endometrial assessments. The…
Platelet function biomarkers and assays for cardiovascular clinical research
HaemAnalytica is a University of Reading biotechnology spin-out developing platelet-function assays for cardiovascular research and clinical trials. Its TRIPLEcheck platform uses platelet biomarkers to predict thrombotic risk and antiplatelet treatment response. PLANA combines preserved blood samples, flow cytometry…
Coronary plaque biomarkers for precision cardiovascular medicine
PlaqueTec develops a catheter-based liquid biopsy system to investigate biological processes driving coronary artery disease. Its device samples blood at sites around coronary plaques, allowing researchers to compare local concentrations of proteins and other molecules. These data feed its BioCarta platform for…
Diagnostic reagents, allergy testing products and contract diagnostics manufacturing
Bio-Diagnostics is a manufacturer of diagnostic products and provider of contract services for the in vitro diagnostics industry. Its own range covers reagents and tests for infectious disease, autoimmunity and immunohistochemistry, alongside an extensive portfolio of allergens and accessories for patch and skin prick…
AI-powered ultrasound analysis software for endometriosis detection
Revela is a medical software company developing machine learning tools to assist in the diagnosis of endometriosis via analysis of ultrasound scans. The software automatically identifies subtle imaging signs associated with endometriosis and returns a structured report to the reviewing clinician, targeting earlier…
Diagnostic reagents, instruments and quality controls for clinical and research laboratories
Randox Laboratories is a global manufacturer of in vitro diagnostic reagents, clinical chemistry analysers, quality control materials, and biochip array technology for laboratory medicine. Products serve clinical, research, molecular, forensic toxicology, food safety, and veterinary laboratory markets across more than…
AI platform predicting patient response to cancer immunotherapy
Curenetics is a medical technology company developing AI-powered tools to predict cancer patient responses to immunotherapy before treatment begins. Its platform integrates multi-omic genomic data, imaging profiles and clinical information to identify biomarkers of treatment efficacy and toxicity. The company also…
Digital microscope platform for veterinary parasite diagnostics
Techion (UK) is the UK subsidiary of New Zealand-founded Techion Group, developer of an integrated digital diagnostics platform for parasite management in production animals. Its FECPAKG2 system combines a portable digital microscope with cloud-based image analysis and decision support software, enabling on-farm…
Blood-based microRNA test for multi-cancer early detection
Xgenera is a diagnostics company developing a blood test for the early detection of multiple cancers from a single sample. The test measures circulating microRNA biomarkers using PCR-based methods and applies machine learning to identify signals from up to 12 common cancers before symptoms appear. The company is…
Solutions for genomics, diagnostics and precision medicine
QIAGEN is a global provider of sample preparation, molecular diagnostics, and genomics solutions for pharmaceutical, clinical, and research applications. Its UK headquarters at Citylabs 2.0, Manchester serves as the company's global centre of excellence for precision medicine and companion diagnostics, co-developing…
Virus-like particle vaccine platform for infectious disease and diagnostics
iQur is a London-based biotechnology company developing vaccines using its proprietary tandem core virus-like particle platform. The technology uses the hepatitis B virus core protein to display multiple antigens simultaneously, stimulating strong immune responses without the risks of live or attenuated viruses.…
AI and photonics platform for personalised drug development
iLoF is a digital health company developing an AI-powered platform that uses proprietary photonics technology to generate optical fingerprints from blood samples, building a cloud-based library of biological profiles and biomarkers. The platform enables non-invasive patient stratification and personalised drug…
PCR reagents and mastermixes for molecular biology research and diagnostics
PCR Biosystems is a developer and manufacturer of PCR reagents for molecular biology research and in vitro diagnostics. Its product range includes DNA polymerases, reverse transcriptases, real-time PCR mastermixes, cDNA synthesis kits, and NGS library amplification reagents, with proprietary hot-start chemistry and…